HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+6.85%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$847M
AUM Growth
+$847M
(+9.5%)
Cap. Flow
+$30.6M
Cap. Flow
% of AUM
3.61%
Top 10 Holdings %
Top 10 Hldgs %
61.2%
Holding
102
New
12
Increased
21
Reduced
2
Closed
1
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$5.67M |
| 2 |
BBL
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
|
$5.21M |
| 3 |
AGN
Allergan plc
AGN
|
$3.12M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$2.69M |
| 5 |
DaVita
DVA
|
$1.56M |
Top Sells
| 1 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
$771K |
| 2 |
Bristol-Myers Squibb
BMY
|
$441K |
Sector Composition
| 1 | Financials | 39.48% |
| 2 | Healthcare | 24.74% |
| 3 | Industrials | 10.63% |
| 4 | Technology | 10.11% |
| 5 | Energy | 5.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $211M | 24.92% | 709 +5 | +0.7% | +$1.49M |
|
2
Wells Fargo
WFC
$263B
| $93.7M | 11.06% | 1,544,420 | – | – |
|
3
IBM
IBM
$227B
| $46.7M | 5.52% | 304,500 +4,300 | +1% | +$660K |
|
4
3M
MMM
$82.8B
| $27M | 3.18% | 114,580 +1,880 | +2% | +$443K |
|
5
Johnson & Johnson
JNJ
$427B
| $24.9M | 2.94% | 177,890 +3,960 | +2% | +$553K |
|
|
6
DaVita
DVA
$9.85B
| $24.1M | 2.85% | 333,920 +21,620 | +7% | +$1.56M |
|
7
Phillips 66
PSX
$54B
| $23.5M | 2.78% | 232,600 +6,100 | +3% | +$617K |
|
|
PX
8
DELISTED
Praxair Inc
PX
| $23.5M | 2.77% | 151,740 +720 | +0.5% | +$111K |
|
9
Novo Nordisk
NVO
$251B
| $22.7M | 2.69% | 423,800 | – | – |
|
10
RTX Corp
RTX
$212B
| $21.1M | 2.5% | 165,650 +4,850 | +3% | +$619K |
|
11
Danaher
DHR
$147B
| $20M | 2.37% | 215,800 | – | – |
|
12
Visa
V
$683B
| $19.6M | 2.31% | 171,900 | – | – |
|
|
POT
13
DELISTED
Potash Corp Of Saskatchewan
POT
| $19.4M | 2.29% | 940,900 | – | – |
|
14
Boeing
BA
$177B
| $19M | 2.24% | 64,300 | – | – |
|
15
Roper Technologies
ROP
$56.6B
| $18.4M | 2.17% | 71,020 +420 | +0.6% | +$109K |
|
16
Wabtec
WAB
$33.1B
| $15.7M | 1.85% | 192,770 +9,470 | +5% | +$771K |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $14.8M | 1.75% | 90,500 +19,100 | +27% | +$3.12M |
|
18
NOV
NOV
$4.94B
| $12M | 1.42% | 333,800 | – | – |
|
19
Gilead Sciences
GILD
$140B
| $10.6M | 1.25% | 147,930 +6,000 | +4% | +$430K |
|
20
Fortive
FTV
$16.2B
| $10.3M | 1.21% | 141,700 | – | – |
|
21
Amgen
AMGN
$155B
| $10.1M | 1.19% | 57,970 | – | – |
|
|
ESRX
22
DELISTED
Express Scripts Holding Company
ESRX
| $10M | 1.19% | 134,600 +36,040 | +37% | +$2.69M |
|
23
Waters Corp
WAT
$18B
| $10M | 1.18% | 51,800 | – | – |
|
|
24
Intuitive Surgical
ISRG
$170B
| $8.51M | 1% | 23,310 +15,540 | +200% | +$5.67M |
|
|
CELG
25
DELISTED
Celgene Corp
CELG
| $7.51M | 0.89% | 71,970 +14,570 | +25% | +$1.52M |
|